Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy
Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy
Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission
Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission
Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business
Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business
Congenica’s Chief Financial Officer Named one of the Top 50 Female Leaders in UK Life Science
Congenica’s Chief Financial Officer Named one of the Top 50 Female Leaders in UK Life Science
Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project
Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project
Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform
Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform
Congenica Finalist in 2017 Biotech and Money Awards
Congenica Finalist in 2017 Biotech and Money Awards
NIHR BioResource and Congenica Finalists for Bio-IT World 2017 Best Practices Award
NIHR BioResource and Congenica Finalists for Bio-IT World 2017 Best Practices Award
Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet
Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet
Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases
Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits
Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits